Innovative and sustainable platforms for the downstream processing of antibody-based biopharmaceuticals
Antibodies, and in particular immunoglobulin G (IgG), are considered as one of the spearheads of the biopharmaceutical industry, presenting high relevance for the treatment of several diseases and being sometimes the only available therapy for some pathologies. Despite their wide potential, the extr...
| Autor principal: | |
|---|---|
| Formato: | doctoralThesis |
| Idioma: | eng |
| Publicado em: |
2024
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10773/33484 |
| País: | Portugal |
| Oai: | oai:ria.ua.pt:10773/33484 |